Concord Wealth Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
VCM
VPM
Concord Wealth Partners's BSX Position: Q1 2026 in Review
Concord Wealth Partners sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 3,907 shares — an estimated $373K sold.
Concord Wealth Partners first reported a position in BSX in Q4 2020 and held it in 20 quarters. The position peaked at $373K in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Concord Wealth Partners reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
- Concord Wealth Partners sold 3,907 Boston Scientific shares in Q1 2026, an estimated $373K.
- Concord Wealth Partners first reported a position in Boston Scientific in Q4 2020 and held it in 20 quarters.
- Concord Wealth Partners's Boston Scientific position peaked at $373K in Q4 2025.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Concord Wealth Partners's 13F filing for Q1 2026, filed 1 May 2026.